Fundamental Analysis
100 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +103.9% | +113.2% | 3 / 3 | +27.7% | +3.11 pp | +2.90 pp | +24.8% | 0.20 | 9.70 | 151 | +27,7% | 11,7 | +103,9% | 9.70 | 14.68 | −33,9% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 49.000 (close price on 2026-07-13)EPS (TTM): 5.050
Financial charts
1.Revenue & growth
VND bn151Q2/26
1.Revenue & growth
VND bn151Q2/26
2.Profit & growth
VND bn11,0Q2/26
3.Profit mix (Penman)
VND bn41,7Q2/26
4.Margins & cost structure
%16.6%Q2/26
5.Returns & cash cycle
% · days24.8%Q2/26
6.Earnings quality & cash
VND bn33,4Q2/26
7.Asset structure
VND bn210Q2/26
8.Funding & debt health
VND bn · times210Q2/26
9.Revenue backlog
VND bn2,65Q2/26
10.Valuation
times · %9,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.653Q2/26
Adjusted EPS growth, latest quarter
91.7%
Average adjusted EPS growth, 3 quarters
109%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26